Percutaneous laser disc decompression (PLDD) is a minimally invasive procedure that aims to significantly reduce the patient’s pain and reduce the neurological deficit.
- Simple and intuitive operation
- Greater precision of treatments with reduced tissue invasiveness
- Quick return to daily activities
- Pain reduction
- No need for hospitalization
- Lowest operating costs
A brief history of laser therapy
In 1986, Peter Ascher and Daniel Choy at the Department of Neurosurgery at the University of Graz in Austria performed the first percutaneous laser disc compression procedure in the lumbar spine.
Since 1987, percutaneous laser disc decompression (PLDD) has been used in the clinical treatment of prolapsed intervertebral discs. Since then, the PLDD technique has spread all over the world, and procedures are performed all over the spine, except for T1 – T4 (these discs do not allow percutaneous access with a needle). This method is widespread in the United States.
The first experimental treatments were carried out on animal intervertebral discs with the use of a neodymium-jag laser – Nd: YAG. The first clinical procedure in history was performed with this laser model. Work on the use of different types of laser led to the introduction of a diode laser into clinical practice.
In Poland, diode laser treatments have been performed since 2003 at the Department of Neurosurgery of the Central Teaching Hospital of the Ministry of Interior and Administration in Warsaw.
|Percutaneous Laser Disc Decompression (PLDD)||
Why is there no single wavelength?
Diode lasers are one of the most efficient converters of electricity to laser light. Thanks to diode lasers, it is possible to induce various tissue reactions, for example coagulation, evaporation or bonding. Diode lasers provide a fairly deep tissue penetration. Various effects can be obtained by changing the laser parameters accordingly, which allows for a wide range of possible applications.
SMARTMNS1 is a laser system that includes a 980 nm diode source and combines the latest technology with ease of use. This combination enables minimally invasive percutaneous disc decompression to be successfully performed. The 980 nm laser radiation is perfectly absorbed by hemoglobin and water molecules, so SMART MNS1 allows you to obtain the vaporization and coagulation effect (without thermal damage). The advantage of optical ablation is that it causes less damage to the surrounding tissues, as well as allows for better hemostasis and permanent effects. SMARTM NS1 is a step forward in laser technology, enabling tissue vaporization, ablation and controlled penetration depth
- Laser type: diode
- Output power: up to 10 W
- Screen: color, touchscreen
- Fiber diameter: 320μm, 400μm, 600μm
- Weight: 2.5 kg
Leave us your e-mail address or telephone number. We will contact you.
Pursuant to Article 13 of the General Data Protection Regulation of 27 April 2016 (Official Journal of the European Union EU L 119 of 04/05/2016) hereinafter referred to as “GDPR”, I hereby inform that:
- the Controller of your personal data is Lasotronix Sp. z o.o. with its registered office at ul. Elektroniczna 2A , 05-500 Piaseczno, Poland
- you can contact the Controller via email at firstname.lastname@example.org
- your personal data will be processed in order to establish contact on the basis of Article 6(1)(f) of the GDPR as a legitimate interest of the Controller and for marketing purposes on the basis of Article 6(1)(a) of the GDPR – consent of the data subject
- the recipients of your personal data will be only entities authorized to obtain personal data under the law, website management entities and mass mailing service providers
- your personal data will be stored until you withdraw your consent; you can withdraw your consent at any time
- you have the right to request from the Controller access to your personal data, the right to rectify, erase or restrict the processing
- you have the right to lodge a complaint with the supervisory authority
- providing personal data is voluntary; however, failure to provide such data may result in the inability to establish contact and receive marketing offers or to participate in surveys